Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-22-012945)

Filing Details

Accession Number:: 0001437749-22-012945
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-18 19:01:34
Reporting Period:: 2022-05-18

Accepted Time:: 2022-05-18 19:01:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434647	Kempharm Inc	KMPH	Pharmaceutical Preparations (2834)	205894398

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1638364	R Matthew Plooster	C/O Kempharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL 34747		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-18	695	$4.94	3,195	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	915	$4.95	4,110	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	3,051	$4.96	7,161	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	339	$4.97	7,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	69	Indirect	By TD Ameritrade Clearing Inc. Custodian FBO Matthew Ryan Plooster Roth IRA, as trustee
Common Stock	1,532	Direct

Footnotes

Held jointly with spouse.